Prevention is the most cost-effective long-term cancer control strategy. In EU-27 and Associated countries, population-based screening programmes exist for three types of cancer (breast, cervical and colorectal cancer), which are often not risk-based. Screening and early detection should become faster, more precise, accessible and affordable. This requires new, sound methods and technologies, including data analytics tools and computing capacities, as well as a robust communication strategy.
The COVID-19 pandemic with its detrimental impact on cancer screening and early detection has demonstrated the need for new and improved screening and early detection solutions.
Proposals under this topic should aim for delivering results that are directed at and contributing to all of the following expected outcomes
- Healthy citizens and cancer patients will benefit from faster, earlier, more precise, personalised, accessible and affordable screening and early detection of cancer.
- Health care professionals will be able to deliver earlier, faster, more precise screening and early detection of cancer.
- Health policy makers will have the evidence to review population-based screening programmes and screening and early detection methodologies in everyday medical practice, and to include new, evidence-based screening and early detection methods, technologies and solutions.
Research is needed to develop and validate non-invasive, or minimally invasive cancer screening and detection methodologies for everyday medical practice and population-based screening programmes, including enhanced participation of the target population. These programmes should become faster, more precise and personalised, affordable and accessible.